APA (7th ed.) Citation

Guiyuan Xiang, Lingna Gu, Xuan Chen, Fan Wang, Bohua Chen, Jie Zhao, . . . Yumei Zhu. (2021). Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Guiyuan Xiang, Lingna Gu, Xuan Chen, Fan Wang, Bohua Chen, Jie Zhao, Yun Lu, Feng Chang, and Yumei Zhu. Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Guiyuan Xiang, et al. Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China. Frontiers Media S.A., 2021.